RDGL
PINK Vivos Inc$0.0458 ↓ -0.0041 (-8.15%) Trading Down from the previous close of $0.0498, and at the day’s high of $0.0499
- YTD change
- -33.60%
- vs 20-day SMA
- -4.92%
- vs 200-day SMA
- -31.79%
Price ranges
Price & Performance
-0.03 (-40.93%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 85.2% away from all-time highs of $0.3100
- RDGL is down 34% since the beginning of the year
- RDGL is down 49% over the past 12 months
- RDGL is down 15% over the past 1 month
- 0% of all RDGL investors are betting against RDGL
RDGL reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -44.1%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0008
- Last 5 days
- -2.01%
- vs 8-day SMA
- -2.93%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. Its product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Kennewick, WA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.